期刊
ENDOCRINE-RELATED CANCER
卷 16, 期 2, 页码 483-490出版社
BIOSCIENTIFICA LTD
DOI: 10.1677/ERC-08-0272
关键词
-
资金
- Associazione Italiana Ricerca sul Cancro (AIRC)
- Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MIUR)
- E C Contract GenRisk-T
- Associazione Partenopea per le Ricerche Oncologiche (APRO)
- NOGEC-Naples Oncogenomic Center
Impairment of the p27(kip1) function, caused by a drastic reduction of its expression or cytoplasmic mislocalization, has been frequently observed in thyroid carcinomas To understand the role of p27(kip1) impairment in thyroid carcinogenesis, we investigated the consequences of the loss of p27(kip1) expression in the context of a mouse modeling of papillary thyroid cancer, expressing the TRK-T1 oncogene under the transcriptional control of thyroglobulin promoter. We found that double mutant mice homozygous for a p27(kip1) null allele (TRK-T1/p27(-/-)) display a higher incidence of papillary thyroid carcinomas, with a shorter latency period and increased proliferation index, compared with p27(kip1) wild-type compounds (TRK-T1/p27(+/+)). Consistently, double mutant mice heterozygous for a p27(kip1) null allele (TRK-T1/p27(+/-)) show an incidence of thyroid carcinomas that is intermediate between TRK-T1/p27(-/-) and TRK-T1/p27(+/+) mice Therefore, our findings suggest a dose-dependent role of p27(kip1) function in papillary thyroid cancer development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据